1-3 of 3
Hildegund C. J. Ertl
Close
Sort by
Journal Articles

Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8 + T cells

Ashley T. Martino, Etiena Basner-Tschakarjan, David M. Markusic, Jonathan D. Finn, Christian Hinderer, Shangzhen Zhou, David A. Ostrov, Arun Srivastava, Hildegund C. J. Ertl, Cox Terhorst, Katherine A. High, Federico Mingozzi, Roland W. Herzog
Journal: Blood
Blood (2013) 121 (12): 2224–2233.
https://doi.org/10.1182/blood-2012-10-460733
Published: 2013
Includes: Supplemental data
Journal Articles

The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9–dependent innate immune responses in the liver

Ashley T. Martino, Masataka Suzuki, David M. Markusic, Irene Zolotukhin, Renee C. Ryals, Babak Moghimi, Hildegund C. J. Ertl, Daniel A. Muruve, Brendan Lee, Roland W. Herzog
Journal: Blood
Blood (2011) 117 (24): 6459–6468.
https://doi.org/10.1182/blood-2010-10-314518
Published: 2011
Includes: Supplemental data
Journal Articles

Adenoviral vectors persist in vivo and maintain activated CD8 + T cells: implications for their use as vaccines

Nia Tatsis, Julie C. Fitzgerald, Arturo Reyes-Sandoval, Kimberly C. Harris-McCoy, Scott E. Hensley, Dongming Zhou, Shih-Wen Lin, Ang Bian, Zhi Quan Xiang, Amaya Iparraguirre, Cesar Lopez-Camacho, E. John Wherry, Hildegund C. J. Ertl
Journal: Blood
Blood (2007) 110 (6): 1916–1923.
https://doi.org/10.1182/blood-2007-02-062117
Published: 2007